Dexorgen Revenue

Biotechnology Research • United States • 1-10 Employees

Dexorgen revenue & valuation

Annual revenue	$513,330
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$1,700,000
Total funding	No funding

Key Contacts at Dexorgen

Zhimin Wang

Senior Director

Jan Van Der Stockt

Ceo

Company overview

Headquarters	United States
Phone number	+12406328810
Websites	dexorgen.com codexbio.com
NAICS	541714
SIC	873
Founded	2009
Employees	1-10
Socials

About Dexorgen

Dexorgen provides cell based assay products and services to academic and governmental research institutes, pharmaceutical and biotechnology industry. The core products of Dexorgen are ACTOne Cell lines and membrane potential kits which are licensed from BD Biosciences. We also develop other new cell based products to meet the demands from various customers. We are also working on the Organoids.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Director

Intern

Employees by Department

Dexorgen has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Dexorgen has never raised funding before.

Dexorgen Tech Stack

Discover the technologies and tools that power Dexorgen's digital infrastructure, from frameworks to analytics platforms.

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

Font Awesome

Font scripts

WordPress

Blogs

TablePress

WordPress plugins

DataTables

JavaScript libraries

Google Maps

Maps

MySQL

Databases

Isotope

JavaScript libraries

RSS

Miscellaneous

Frequently asked questions

Dexorgen is located in US.

You can reach Dexorgen at +12406328810.

Dexorgen generates an estimated annual revenue of $513,330. This revenue figure reflects the company's market position and business performance in its industry.

Dexorgen has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Dexorgen was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Dexorgen has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Dexorgen

Zhimin Wang

Senior Director

Jan Van Der Stockt

Ceo

4.8

40,000 users